A HET-CAM based vascularized intestine tumor model as a screening platform for nano-formulated photosensitizers-Reference-Cited by-同舟云学术

A HET-CAM based vascularized intestine tumor model as a screening platform for nano-formulated photosensitizers

Published:2022-01 Issue: Volume:168 Page:106046
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Elberskirch Linda,Le Harzic Ronan,Scheglmann Dietrich,Wieland Gerhard,Wiehe Arno,Mathieu-Gaedke Maria,Golf Hartwig R.A.,von Briesen Hagen,Wagner Sylvia

Funder

BMBF Berlin

Bundesministerium für Bildung und Forschung

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Development of polymeric cargo for delivery of photosensitizer in photodynamic therapy;Bae;Int. J. Photoenergy.,2012

2. Optimization of treatment parameters for Foscan®-PDT of basal cell carcinomas;Betz;Lasers Surg. Med.,2008

3. Photodynamic therapy of head and neck cancers;Biel;Methods Mol. Biol.,2010

4. Evaluation of mTHPC-loaded PLGA nanoparticles for in vitro photodynamic therapy on C6 glioma cell line;Bœuf-Muraille;Photodiagnosis Photodyn. Ther.,2019

5. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers;Bonnett;Biochem. J.,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged Release Niosomes For Ocular Delivery of Loteprednol: Ocular Distribution Assessment on Dry Eye Disease Induced Rabbit Model;AAPS PharmSciTech;2024-05-30

2. Exploring Current In Vitro Models for Cancer Research;Interdisciplinary Cancer Research;2024

3. In Vitro Evaluation of Anti-Angiogenic Efficacy, Cell Migration Activity and Cell Survival Effect Against Hydrogen Peroxide-Induced Damage of Prunetin;Pharmaceutical Chemistry Journal;2023-09

4. The Photosensitizer Temoporfin ( m THPC ) – Chemical, Pre‐clinical and Clinical Developments in the Last Decade ^† ^‡;Photochemistry and Photobiology;2022-11-03

5. In ovo model in cancer research and tumor immunology;Frontiers in Immunology;2022-09-29